MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer’s disease

Lewczuk, 2010, Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study, Mol Psychiatry, 15, 138, 10.1038/mp.2008.84

Weiner, 2013, Dementia in 2012: Further insights into Alzheimer disease pathogenesis, Nat Rev Neurol, 2, 65, 10.1038/nrneurol.2012.275

Singer, 2005, Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model, Nat Neurosci, 8, 1343, 10.1038/nn1531

Tan, 2013, Non-coding RNAs in Alzheimer’s disease, Mol Neurobiol, 47, 382, 10.1007/s12035-012-8359-5

Junn, 2012, MicroRNAs in neurodegenerative diseases and their therapeutic potential, Pharmacol Ther, 133, 142, 10.1016/j.pharmthera.2011.10.002

Delay, 2012, MicroRNAs in Alzheimer’s disease, Neurobiol Dis, 46, 285, 10.1016/j.nbd.2012.01.003

Hébert, 2009, Alterations of the microRNA network cause neurodegenerative disease, Trends Neurosci, 32, 199, 10.1016/j.tins.2008.12.003

Long, 2011, MicroRNA-101 downregulates Alzheimer’s amyloid-β precursor protein levels in human cell cultures and is differentially expressed, Biochem Biophys Res Commun, 404, 889, 10.1016/j.bbrc.2010.12.053

Delay, 2011, Alzheimer-specific variants in the 3′UTR of Amyloid precursor protein affect microRNA function, Mol Neurodegener, 6, 70, 10.1186/1750-1326-6-70

Hébert, 2010, Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration, Hum Mol Genet, 19, 3959, 10.1093/hmg/ddq311

Blennow, 2010, Cerebrospinal fluid and plasma biomarkers in Alzheimer disease, Nat Rev Neurol, 6, 131, 10.1038/nrneurol.2010.4

Rembach, 2014, AIBL research group, Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer’s disease, Alzheimers Dement, 10, 53, 10.1016/j.jalz.2012.12.006

Lewczuk, 2010, Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer’s disease: a multicenter study, Mol Psychiatry, 15, 138, 10.1038/mp.2008.84

Zetterberg, 2008, Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease, Arch Neurol, 65, 1102, 10.1001/archneur.65.8.1102

Wang, 2011, Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter, Acta Neuropathol, 2, 193, 10.1007/s00401-010-0756-0

Schonrock, 2010, Neuronal microRNA deregulation in response to Alzheimer’s disease amyloid-beta, PLoS One, 5, e11070, 10.1371/journal.pone.0011070

Hosseini, 2013, The role of exosomes in infectious diseases, Inflamm Allergy Drug Targets, 1, 29, 10.2174/1871528111312010005

Pant, 2012, The multifaceted exosome: biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities, Biochem Pharmacol, 11, 1484, 10.1016/j.bcp.2011.12.037

Boon, 2013, Intercellular transport of microRNAs, Arterioscler Thromb Vasc Biol, 33, 186, 10.1161/ATVBAHA.112.300139

Wei, 2011, Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis, Int J Parasitol, 41, 1175, 10.1016/j.ijpara.2011.07.002

Wang, 2008, The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1, J Neurosci, 5, 1213, 10.1523/JNEUROSCI.5065-07.2008

Liu, 2007, 17Beta-oestradiol regulates the expression of Na+/K+-ATPase beta1-subunit, sarcoplasmic reticulum Ca2+-ATPase and carbonic anhydrase iv in H9C2 cells, Clin Exp Pharmacol Physiol, 34, 998, 10.1111/j.1440-1681.2007.04675.x

Dassow, 2013, MicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapy, Curr Pharm Des, 19, 1242

Eulalio, 2012, The mammalian microRNA response to bacterial infections, RNA Biol, 9, 742, 10.4161/rna.20018

Mitchell, 2008, Circulating microRNAs as stable blood-based markers for cancer detection, Proc Natl Acad Sci USA, 105, 10513, 10.1073/pnas.0804549105

Giedraitis, 2007, The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer’s disease, Neurosci Lett, 427, 127, 10.1016/j.neulet.2007.09.023

Vickers, 2011, MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins, Nat Cell Biol, 4, 423, 10.1038/ncb2210

van Leuven, 2000, Single and multiple transgenic mice as models for Alzheimer’s disease, Prog, Neurobiol, 61, 305

Ceruti, 2011, Oxygen-glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood-brain barrier, Neurochem Int, 59, 259, 10.1016/j.neuint.2011.05.013

Ma, 2012, Circulating microRNAs in cancer: origin, function and application, J Exp Clin Cancer Res, 31, 38, 10.1186/1756-9966-31-38